Seven Vaccines After 50, and Nobody Is Keeping the List for You
What each shot is for, how often it comes around, how to pull your own record, and what that record cannot tell you.
What each shot is for, how often it comes around, how to pull your own record, and what that record cannot tell you.
What changed for adults 50 to 74, where the real eligibility list is kept, and why a 53-year-old with a genuine cardiovascular problem still cannot tell whether it includes him.
Moderna’s mFLUSIVA was approved on August 5. The most interesting thing about it is what its own approval failed to demonstrate.
I have three Thorne products in my cabinet. Here is what the P&G Thorne acquisition actually changes, based on the brands bought before it.
A trademark, a Netflix series, and about $100,000 a year for a city to keep the certification. The business kept growing while the science underneath it kept shrinking.
The FDA’s compounding committee voted on seven peptides, recommending BPC-157. What peptides are, why the market exploded, and what the vote does and does not decide.
My TRT clinic prescribed 5 mg of tadalafil a day. Here is what it is actually proven to do for the prostate and ED, what the podcasts oversell, and the one drug interaction to never ignore.
I take a diabetes drug and have never had diabetes. A plain-English map of the type 2 diabetes drugs, and why the best ones now protect your heart and kidneys, not just blood sugar.
A cyclospora outbreak just sickened 1,645 people across 34 states, and romaine keeps causing E. coli recalls. Is romaine lettuce safe to eat, and is it even worth it? A hard look, and what I eat instead.
Finding purpose in retirement is the part no one plans for. Why a project beats a blank calendar, what the research on hobbies and mattering shows, and how to start before you retire.